REMARV
Live / Registered — Registered (as of 09 Dec 2025)
What this means for you
Registered since 09 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98431810
- Registration number
- 8055439
- Mark type
- Stylized text
- Filed
- 04 Mar 2024
- Published for opposition
- 29 Oct 2024
- Registered
- 09 Dec 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GLAXO GROUP LIMITED, Stevenage, GB
- GLAXO GROUP LIMITED, Stevenage, GB
- GLAXO GROUP LIMITED, Stevenage, GB
Prosecution history
- 09 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 10 Jun 2025 — NOTICE OF ALLOWANCE CANCELLED
- 10 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jun 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 10 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION
- 09 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Sept 2024 — ASSIGNED TO EXAMINER
- 04 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Mar 2024 — NEW APPLICATION ENTERED